Nutritional and Metabolic Diseases Clinical Trial
Official title:
A Mild Supplementation of Arabinoxylan Fiber Improves Homa Index in Overweight and Obese Subjects. Results From a Randomized Cross Over Trial.
The study aimed to investigate whether an Arabinoxylan-enriched crackers consumption for 4 weeks in overweight and obese patients without diabetes mellitus have specific healthy effects on glycemic control (reduction of homeostatic model assessment -HOMA index-). Furthermore, study evaluated the effects of Arabinoxylan on insulin, lipid and Ghrelin.
The beneficial effects of soluble dietary fiber to health are well known: many studies show clearly that it delays the onset of cardiovascular disease and some cancers, and improves glycemic control in type 2 diabetes. (1,2). Overweight and obesity are known to be associated with increased rate of diabetes, hypertension and cardiovascular diseases, as well as to colon and breast cancer. The introduction of 25-30gr of dietary fiber daily would therefore indicated not only in type 2 diabetic subjects, but also in obese and overweight patients. Most of the foods commonly consumed in Western countries are low in dietary fiber: to reach the recommended levels people should introduce whole grain cereals, legumes, vegetables and dried fruits, not always accepted. We tested the effects on health of crackers baked with a special Integralbianco® flour, enriched with 3,2g of Arabinoxylan / 100g (vs refined flour). ;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00682604 -
The Nutritional Status and Food Intake of Community Health Agents
|
N/A | |
| Completed |
NCT01199848 -
A Study of Strawberries and Disease Risk
|
N/A | |
| Recruiting |
NCT05998772 -
Influence of Glucose on Metabolism and Clinical Symptoms of Patients With Parkinson's Disease
|
||
| Not yet recruiting |
NCT04969809 -
Comparison of Atherogenic Risk Factors and Efficacy of Nutritional Treatment Among Adult Phenylketonuria Patients
|
N/A | |
| Completed |
NCT03676309 -
Efficacy and Safety of Nutraceuticals in Patients With Diabetes Mellitus Type II and Dyslipidemia.
|
Phase 2 | |
| Active, not recruiting |
NCT02959762 -
Vitamin K to Slow Progression of Dyslipidemia and Diabetes Risk (Vita-K 'n' Kids Study II)
|
N/A | |
| Completed |
NCT01708681 -
Lean Seafood Intake and Postprandial Metabolism
|
N/A | |
| Completed |
NCT05244785 -
Health and Nutrition Survey on Shenzhen Children
|
||
| Completed |
NCT04787952 -
Insight Into New Brown Adipose Tissue Activators.
|
||
| Completed |
NCT03451994 -
Exploratory Study of Volatile Organic Compounds in Alveolar Breath
|
||
| Recruiting |
NCT05540678 -
The FibreGum Study - Changing the Course of Obesity in Children
|
N/A | |
| Completed |
NCT00622765 -
A Study of the Safety and Effectiveness of JNJ-16269110 (R256918) in Overweight and Obese Patients
|
Phase 2 | |
| Completed |
NCT02718885 -
Gut Microbiome Mediated Effects of Inulin Supplementation on Mineral and Bone Metabolism in Hemodialysis Patients
|
Early Phase 1 | |
| Completed |
NCT01682343 -
Effect of High-calcium Intake on Appetite, Insulinemia and Incretins
|
N/A | |
| Active, not recruiting |
NCT05484999 -
The Maternal Well-Being Study
|
N/A | |
| Completed |
NCT04688073 -
Effect of Muscle Damage After Downhill Running on Postprandial Lipids
|
N/A | |
| Completed |
NCT03166540 -
Bioavailability and Beneficial Properties of Coffee and Cocoa Bioactive Compounds
|
N/A | |
| Completed |
NCT02685137 -
Efficacy and Safety of Stannsoporfin in Neonates
|
Phase 3 | |
| Completed |
NCT05964179 -
Effects of Daily Eating Duration on Health
|
N/A | |
| Recruiting |
NCT06386471 -
Personalized GI Motility Responses to Diet
|
N/A |